|
Market Closed -
Nasdaq
06:00:00 19/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 29.03 USD | -3.07% |
|
-9.96% | -25.37% |
| 17/08 | Castle Biosciences Gets Approval for Dual Listing on Nasdaq Texas | MT |
| 31/07 | Castle Biosciences, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
| Market Cap | 887M 766M 721M 655M 1.23B 84.97B 1.25B 8.45B 3.31B 42.5B 3.33B 3.26B 142B | P/E 2026 * |
-22.8x | P/E 2027 * | -29.4x |
|---|---|---|---|---|---|
| Enterprise Value | 887M 766M 721M 655M 1.23B 84.97B 1.25B 8.45B 3.31B 42.5B 3.33B 3.26B 142B | EV / Sales 2026 * |
2.38x | EV / Sales 2027 * | 2.17x |
| Free-Float |
97.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Castle Biosciences, Inc.
| 1 day | -3.07% | ||
| 1 week | -9.96% | ||
| Current month | +3.68% | ||
| 1 month | +20.16% | ||
| 3 months | +50.26% | ||
| 6 months | -13.78% | ||
| Current year | -25.37% |
| 1 week | 28.72 |  | 31.97 |
| 1 month | 23.25 | | 33.06 |
| Current year | 17.72 | | 44.28 |
| 1 year | 17.72 | | 44.28 |
| 3 years | 12.07 | | 44.28 |
| 5 years | 9.26 | | 78.58 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 01/09/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 01/12/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 01/09/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 01/09/2014 |
G. Cole
BRD | Director/Board Member | 70 | 06/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/8/26 | Fiscal year | Founder | 8,667 | 0.0286% | ||
| 3/8/26 | Sell | Chief Operating Officer | -8,586 | 0.0283% | ||
| 3/8/26 | Sell | Executive/Senior Manager | -1,730 | 0.0057% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.07% | -9.96% | +41.20% | +65.32% | 887M | |
| -0.96% | -3.01% | +169.24% | +332.64% | 21.49B | |
| -1.10% | -1.30% | -43.18% | -22.49% | 9.93B | |
| -4.07% | -4.87% | +313.30% | +21.78% | 7.25B | |
| -0.64% | -0.42% | +79.13% | +51.27% | 6.54B | |
| -3.05% | -9.38% | -41.67% | - | 5.93B | |
| +3.89% | +10.64% | -9.25% | -1.00% | 6.23B | |
| -1.73% | +4.96% | +83.03% | +114.77% | 4.62B | |
| -0.49% | -0.92% | -14.60% | -17.98% | 4.22B | |
| +4.53% | +5.33% | -17.16% | -27.68% | 2.91B | |
| Average | -0.67% | -0.99% | +56.00% | +57.40% | 7B | |
| Weighted average by Cap. | -0.84% | -1.19% | +85.71% | +122.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 373M 322M 303M 275M 518M 35.73B 526M 3.55B 1.39B 17.87B 1.4B 1.37B 59.52B | 409M 354M 333M 302M 569M 39.23B 577M 3.9B 1.53B 19.62B 1.54B 1.5B 65.35B |
| Net income | -38.03M -32.85M -30.91M -28.09M -52.83M -3.64B -53.61M -363M -142M -1.82B -143M -140M -6.07B | -27.75M -23.97M -22.55M -20.5M -38.55M -2.66B -39.12M -265M -104M -1.33B -104M -102M -4.43B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | USD 29.03 | -3.07% | 596,609 |
| 17/08/26 | USD 29.95 | +1.11% | 225,807 |
| 14/08/26 | USD 29.62 | -3.04% | 264,212 |
| 13/08/26 | USD 30.55 | -2.80% | 362,229 |
| 12/08/26 | USD 31.43 | -2.51% | 435,995 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
